A. R. Carson, C. F. Mctiernan, L. Lavery, M. Grata, X. Leng et al., Ultrasound-targeted microbuble destruction to deliver siRNA cancer therapy, Cancer Res, vol.72, pp.6191-6199, 2012.

J. J. Choi, K. Selert, F. Vlachos, A. Wong, and E. E. Konofagou, Noninvasive and localized neuronal delivery using short ultrasound pulsed and microbubbles, Proc. Natl. Acad. Sci. U. S. A, vol.108, pp.16539-16544, 2011.

S. J. Grainger, J. V. Serna, S. Sunny, Y. Zhou, C. X. Deng et al., Pulsed ultrasound enhances nanoparticle penetration into breast cancer spheroids, Mol. Pharm, vol.7, 2006.

P. Hauff, S. Seemann, R. Reszka, M. Scultze-mosgau, M. Reinhardt et al., Evaluation of gas-filled microparticles and sonoporation as gene delivery system: feasibility study in rodent tumor models, Radiology, vol.236, pp.572-578, 2005.

M. Ingargiola, R. Runge, J. M. Heldt, R. Freudenberg, J. Steinbach et al., Potential of a cetuximab-based radioimmunotherapy combined with external irradiation manifests in a 3-D cell assay, Int. J. Cancer, vol.135, pp.968-980, 2014.

Y. Komarova and A. B. Malik, Regulation of endothelial permeability via paracellular and transcellular transport pathways, Ann. Rev. Physiol, vol.72, pp.463-493, 2010.

A. H. Kyle, L. A. Huxham, A. S. Chiam, D. H. Sim, and A. I. Minchinton, Direct assessment of drug penetration into tissue using a novel application of threedimensional cell culture, Cancer Res, vol.64, pp.6304-6309, 2004.

A. H. Kyle, L. A. Huxham, D. M. Yeoman, and A. I. Minchinton, Limited tissue penetration of taxanes: a mechanism for resistance in solid tumors, Cancer Res, vol.13, pp.2804-2810, 2007.

I. Lentacker, I. De-cock, R. Deckers, S. C. De-smidt, and C. T. Moonen, Understanding ultrasound induced sonoporation: definitions and underlying mechanisms, Adv. Drug Deliv. Rev, vol.72, pp.49-64, 2014.

A. A. Manzoor, L. H. Lindner, C. D. Landon, J. Y. Park, A. J. Simnick et al., Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors, Cancer Res, vol.72, pp.5566-5575, 2012.

D. W. Mcmillin, J. M. Negri, and C. S. Mitsiades, The role of tumourstromal interactions in modifying drug response: challenges and opportunities, Nat. Rev. Drug Discov, vol.12, pp.217-228, 2013.

A. I. Minchinton and I. F. Tannock, Drug penetration in solid tumors, Nat. Rev. Cancer, vol.6, pp.583-592, 2006.

T. Nhan, A. Burgess, E. E. Cho, B. Stefanovic, L. Lilge et al., Drug delivery to the brain by focused ultrasound induced blood-brain barrier disruption: quantitative evaluation of enhanced permeability of cerebral vasculature using two-photon microscopy, J. Control. Release, vol.172, pp.274-280, 2013.

H. Nishihara, Human pathological basis of blood vessels and stromal tissue for nanotechnology, Adv. Drug Deliv. Rev. doi, 2014.

A. J. Primeau, A. Rendon, D. Hedley, L. Lilge, and I. F. Tannock, The distribution of the anticancer drug doxorubicin in relation to blood vessels in solid tumors, Clin. Cancer Res, vol.11, pp.8782-8788, 2005.

S. M. Sagnella, H. Duong, A. Macmillan, C. Boyer, R. Whan et al., Dextran-based doxorubicin nanocarriers with improved tumor penetration, Biomacromolecules, vol.15, pp.262-275, 2014.

S. Tinkov, C. Coester, S. Serba, N. A. Geis, H. A. Katus et al., New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization, J. Control. Release, vol.148, pp.368-372, 2010.